| Literature DB >> 31737523 |
Yichao Duan1,2, Xing Zhou3, Hongling Su2, Kaiyu Jiang2, Wenyu Wu1,2, Xin Pan4, Guanming Qi5, Yan Zhang6, Yunshan Cao2.
Abstract
Fibrosing mediastinitis (FM) is a very rare disease, often caused by histoplasmosis capsulatum, tuberculosis, sarcoidosis, autoimmunity and other diseases, such as IgG 4-related diseases. Fibrous structures in the mediastinum compress the pulmonary artery, pulmonary vein, superior vena cava, esophagus, trachea and cardiac vessels, leading to clinical symptoms. Drug therapeutic modality for pulmonary vein stenosis (PVS) caused by FM is palliative in essence and with limited efficacy, whereas surgical treatment causes high mortality. In recent years, catheter-based treatment to FM-caused PVS has emerged as a promising therapeutic modality, however, the safety and effectiveness of this modality remain unclear. Therefore, a systematic review on the safety and efficacy of the catheter-based treatment for PVS caused by FM was performed, in the hope to shed lights on the alternative therapeutic strategy to this fatal disease. 2019 Cardiovascular Diagnosis and Therapy. All rights reserved.Entities:
Keywords: Fibrosing mediastinitis (FM); balloon angioplasty; catheter; pulmonary vein stenosis (PVS); pulmonary vein stent
Year: 2019 PMID: 31737523 PMCID: PMC6837911 DOI: 10.21037/cdt.2019.09.14
Source DB: PubMed Journal: Cardiovasc Diagn Ther ISSN: 2223-3652